Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
ipo
life sciences
national blog main
national top stories
san francisco
3
×
san francisco blog main
san francisco top stories
cancer
cancer drugs
revolution medicines
sanofi
the column group
third rock ventures
warp drive bio
amgen
antibiotics
arvinas
astrazeneca
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
cobimetinib
colorectal cancer
deals
detroit
detroit blog main
detroit top stories
drugs
entasis therapeutics
fda
gritstone oncology
guardant health
indiana
What
ipo
3
×
cancer
medicines
proteins
research
revolution
way
biotechs
cancer’s
chose
close
company
despite
device
disease
drug
family
firms
frontiers
hardest
hit
hottest
hunters
ipos
known
life
make
maps
medical
open
parlance
pharmaceutical
play
q
quarter
ras
reach
reels
revealed
role
Language
unset
Current search:
ipo
×
" san francisco "
×
" boston blog main "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way